Last reviewed · How we verify
Inulin placebo tablets
Inulin placebo tablets is a Small molecule drug developed by Second Xiangya Hospital of Central South University. It is currently FDA-approved for Clinical trial control agent (not a therapeutic indication).
Inulin is an inert polysaccharide that serves as a placebo control and does not exert pharmacological effects on the body.
Inulin placebo tablets have been used in clinical trials to study various conditions, including metabolic syndrome, stress, gut bacteria, and insulin resistance. The mechanism of inulin is unknown, but it is derived from the root of the chicory plant and is also known as inulin and inulin and sodium chloride.
At a glance
| Generic name | Inulin placebo tablets |
|---|---|
| Sponsor | Second Xiangya Hospital of Central South University |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Inulin is a naturally occurring fructose polymer that is poorly absorbed in the human gastrointestinal tract and is metabolically inert. As a placebo tablet formulation, it is used as a control agent in clinical trials to assess the placebo effect and distinguish true drug efficacy from non-specific therapeutic responses. It has no known molecular targets or direct pharmacological activity.
Approved indications
- Clinical trial control agent (not a therapeutic indication)
Common side effects
- Gastrointestinal disturbance (potential, due to inulin's osmotic properties)
Key clinical trials
- Human Models of Selective Insulin Resistance: Alpelisib, Part I (PHASE1)
- Polyphenols, Prebiotics, the Gut Microbiome and Stress (NA)
- Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA (PHASE4)
- Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome (PHASE3)
- Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic Syndrome (PHASE3)
- Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy People (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Inulin placebo tablets CI brief — competitive landscape report
- Inulin placebo tablets updates RSS · CI watch RSS
- Second Xiangya Hospital of Central South University portfolio CI
Frequently asked questions about Inulin placebo tablets
What is Inulin placebo tablets?
How does Inulin placebo tablets work?
What is Inulin placebo tablets used for?
Who makes Inulin placebo tablets?
What development phase is Inulin placebo tablets in?
What are the side effects of Inulin placebo tablets?
Related
- Manufacturer: Second Xiangya Hospital of Central South University — full pipeline
- Indication: Drugs for Clinical trial control agent (not a therapeutic indication)
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing